WO2007123113A1 - ホエープロテイン含有顆粒およびその製造方法 - Google Patents
ホエープロテイン含有顆粒およびその製造方法 Download PDFInfo
- Publication number
- WO2007123113A1 WO2007123113A1 PCT/JP2007/058329 JP2007058329W WO2007123113A1 WO 2007123113 A1 WO2007123113 A1 WO 2007123113A1 JP 2007058329 W JP2007058329 W JP 2007058329W WO 2007123113 A1 WO2007123113 A1 WO 2007123113A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- whey protein
- fatty acid
- ester
- acid ester
- granules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Definitions
- the present invention relates to a granule containing whey protein and a method for producing the same.
- JP-A-63-22172 discloses a powdered and granular food composition comprising whey powder or the like containing a liquid or pasty surfactant for food. This is mixed with whey powder in order to improve the handling property of viscous food-grade surfactants, and is not related to the solubility of whey itself, so the surfactant content is high. Is.
- JP-A-10-84868 and JP-A-2003-189799 disclose a milk substitute composition containing as a main component whey, which contains lecithin and a polyoxyethylene glycerin fatty acid ester. Has been. This suppresses the separation of fats and oils in the milk substitute. It contains 10% by weight or more of fats and oils and is not related to the dissolution of whey powder. Furthermore, as far as the present inventors know, when these compositions disclosed in the prior art are dissolved in water, all become turbid and not transparent.
- the present inventors have recently found that the solubility of whey protein-containing granules and the transparency of the solution after dissolution are significantly improved by specific polyglycerol fatty acid esters.
- the present invention is based on such knowledge.
- an object of the present invention is to provide a whey protein-containing granule having improved solubility and further transparency of the solution after dissolution.
- Another object of the present invention is to provide a method for producing the whey protein-containing granules.
- a whey protein-containing granule according to one embodiment of the present invention comprises a polyglycerin fatty acid ester having lauric acid as a constituent fatty acid and having an HLB of 13-18.
- the method for producing whey protein-containing granules includes a whey protein having a HLB of 13 to 18, a polyglycerol fatty acid ester having lauric acid as a constituent fatty acid, and optionally a noinder. And a granulating step.
- a whey mouth tin is optionally granulated with a binder to obtain a granule, and the granule has 13 to 18 HLB.
- a step of adding a polyglycerol fatty acid ester having lauric acid as a constituent fatty acid is optionally granulated with a binder to obtain a granule, and the granule has 13 to 18 HLB.
- the polyglycerin fatty acid ester contained in the whey protein-containing granule according to the present invention contains lauric acid having a HLB of 13 to 18 as a constituent fatty acid.
- the HLB value of the polydaricelin fatty acid ester is in the range of 13 to 18, preferably 14 to 16. When the HLB value is in this range, the granules become obscured when dissolved, and an aqueous solution with high transparency is obtained.
- HLB is the hydrophilic nature of surfactant molecules. This is a quantitative representation of the balance between the relative strength of the oil and lipophilicity. The larger the HLB, the higher the hydrophilicity.
- the polyglycerol fatty acid ester includes one or more glycerol units in the molecule, preferably 1 to 15, more preferably 5 to 10.
- the number may be determined within the range where the above HLB value can be realized.
- the number of esters with lauric acid is one.
- the position of the ester can be appropriately determined within the range in which the above HLB value can be realized, but a hydroxyl group near the end of the molecule is preferable.
- polyglycerol fatty acid ester in the present invention can include a case where the glycerol unit in the molecule is 1, it may be simply referred to as “glycerol fatty acid ester”.
- the polyglycerol fatty acid ester contained in the whey protein-containing granule according to the present invention is preferably a compound represented by the following formula (I).
- n an integer of 1 to 15.
- the polyglycerin fatty acid ester contained in the whey protein-containing condyles according to the present invention is preferably monolauric acid decaglycerin ester or monolauric acid pentaglycerin ester.
- the addition amount of the polyglycerin fatty acid ester is not particularly limited. It is preferably about 0.5 to 3% by weight based on the whey protein-containing granule. If the added amount is within this range, it is possible to effectively prevent fooling. On the other hand, if the amount added is large, it may affect the taste of foods and the like to which the whey protein-containing granule according to the present invention is added in some cases. [0016] When the whey protein-containing granule according to the present invention is dissolved in water, the transparency of the solution is high.
- the light transmittance at a wavelength of 800 ⁇ m when dissolved by 5 parts by weight with respect to 100 parts by weight of water is 80% or more, and according to a preferred embodiment, it is 90% or more.
- the transmittance was determined by preparing an aqueous solution in which 5 parts by weight of whey protein-containing granules were dissolved in 100 parts by weight of water, and irradiating a 10 mm wide cell containing the aqueous solution with light having a wavelength of 800 nm. The transmittance was measured using water as a comparison target.
- the pH force of the aqueous solution in which whey protein-containing granules are dissolved is preferably near the isoelectric point (pH 4 to 5) of whey protein because precipitation occurs!
- the pH of the aqueous solution in which the whey protein-containing granules are dissolved is more preferably pH 2.5 to 3.7 or pH 6 to 7.5.
- the pH measurement temperature is 25 ° C.
- the whey protein-containing granule according to the present invention may be a whey protein-containing granule produced by a known or commonly used method except that it contains the above-mentioned polyglycerin fatty acid ester. Therefore, the whey protein-containing granule according to the present invention can be produced by fluidized bed granulation, rolling granulation, extrusion granulation, stirring granulation or the like.
- binders that preferably use a binder for granulation include aqueous solutions of thickening polysaccharides such as pullulan, gum arabic, guar gum, xanthan gum, locust bean gum and the like.
- the polyglycerin fatty acid ester added to the granule is mixed with a powder raw material such as whey protein before granulation, added at the time of granulation, or added to the granule after granulation (for example, Or spray as an aqueous solution as it is to cover a part or all of the granule).
- a powder raw material such as whey protein before granulation, added at the time of granulation, or added to the granule after granulation (for example, Or spray as an aqueous solution as it is to cover a part or all of the granule).
- the method for producing a whey protein-containing granule includes a whey protein having a polyglycerin fatty acid ester having HLB of 13 to 18 and lauric acid as a constituent fatty acid.
- a step of granulating together with a binder includes a whey protein having a polyglycerin fatty acid ester having HLB of 13 to 18 and lauric acid as a constituent fatty acid.
- whey protein is optionally granulated with a binder to obtain granules, and the obtained granules have an HLB of 13 to 18.
- a polyglycerin fatty acid containing lauric acid as a constituent fatty acid The method includes a step of adding steal, and the additive is preferably carried out by spraying an aqueous solution thereof.
- the mode of adding the polyglycerol fatty acid ester by spraying is preferable because the polyglycerol fatty acid ester can be uniformly coated on the entire granule.
- the amount of whey protein in the whey protein-containing granule according to the present invention is not particularly limited, but it can be preferably applied to a granule of 30% by weight or more, and may have a high content of 60 to 95% by weight.
- the content of whey protein is calculated based on the weight power of the granule as a final product and the dry weight excluding moisture as 100% by weight.
- the whey protein-containing granule according to the present invention may be used as it is or may be used as a composition together with a carrier suitable for its use. For example, it is used as food or medicine.
- a composition comprising the whey protein-containing granules according to the present invention together with a carrier.
- a food or pharmaceutical product comprising the whey protein-containing granule according to the present invention is provided.
- the whey protein-containing granule according to the present invention may contain other components according to its use.
- it can contain raw materials contained in normal food granules, and sugars such as sucrose, glucose, maltose, fructose, lactose, trehalose, sorbitol, maltitol, xylitol, oligosaccharides, dextrin, soluble starch, etc.
- Acids such as citrate, malic acid, tartaric acid and lactic acid, sweeteners such as stevia, aspartame, sucralose and acesulfame potassium, thickeners such as pullulan, gum arabic, guar gum, xanthan gum and locust bean gum, calcium, magnesium , Minerals such as potassium, iron and sodium, vitamins such as vitamin, group k, group B, C, D, E and K, amino acids such as norin, leucine, isoleucine, glutamine, lysine and methionine, vanilla flavoring, milk It can contain fragrances such as fragrance, fruit fragrance, and drink fragrance. That.
- Test example Whey protein 75 parts by weight, lactose 14.9 parts by weight, with mixing at Kuen acid 8.7 parts by weight of the fluidized bed take into granulator 65 ° C, pullulan 5 weight 0/0, 1 wt% sucralose Granulation was carried out by spraying 10 parts by weight of a binder solution dissolved in water. After spraying was completed, it was dried at 85 ° C. until the water content became 3% by weight, and cooled to room temperature to obtain granules.
- Each granule was sprayed with 1.6 parts by weight of a spray solution prepared by mixing various weights of the emulsifiers shown in Table 1 with water (for Comparative Example 9, the total amount of water) to obtain whey protein-containing granules as the final product.
- the resulting whey protein-containing granules (10 g) were placed in water at 25 ° C and 200 g and examined for the occurrence of litter when they were dissolved by stirring uniformly with a spatula for 15 seconds.
- permeability of the light of wavelength 800nm of the obtained aqueous solution was measured using the spectrophotometer (Shimadzu Corporation make: UV-2400PC). Each aqueous solution had a pH of 3.3. The results are shown in Table 1.
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2007241926A AU2007241926B2 (en) | 2006-04-17 | 2007-04-17 | Whey protein-containing granules and method of producing the same |
EP07741765.7A EP2027777B1 (en) | 2006-04-17 | 2007-04-17 | Whey protein-containing granules and method of producing the same |
US12/226,354 US8071153B2 (en) | 2006-04-17 | 2007-04-17 | Whey protein-containing granules and method of producing the same |
JP2008512114A JP5095610B2 (ja) | 2006-04-17 | 2007-04-17 | ホエープロテイン含有顆粒およびその製造方法 |
CA2649619A CA2649619C (en) | 2006-04-17 | 2007-04-17 | Whey protein-containing granules and method of producing the same |
CN2007800179645A CN101448406B (zh) | 2006-04-17 | 2007-04-17 | 含乳清蛋白质的颗粒及其制备方法 |
HK09107665.0A HK1129815A1 (en) | 2006-04-17 | 2009-08-20 | Whey protein-containing granules and method of producing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006113189 | 2006-04-17 | ||
JP2006-113189 | 2006-04-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007123113A1 true WO2007123113A1 (ja) | 2007-11-01 |
Family
ID=38625013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/058329 WO2007123113A1 (ja) | 2006-04-17 | 2007-04-17 | ホエープロテイン含有顆粒およびその製造方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US8071153B2 (ja) |
EP (1) | EP2027777B1 (ja) |
JP (1) | JP5095610B2 (ja) |
KR (1) | KR101034411B1 (ja) |
CN (1) | CN101448406B (ja) |
AU (1) | AU2007241926B2 (ja) |
CA (1) | CA2649619C (ja) |
HK (1) | HK1129815A1 (ja) |
WO (1) | WO2007123113A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009242308A (ja) * | 2008-03-31 | 2009-10-22 | Terumo Corp | 水易溶解性高たんぱく粉末栄養組成物およびその製造方法 |
JP2015188373A (ja) * | 2014-03-28 | 2015-11-02 | 株式会社ファンケル | 顆粒剤 |
JP2016079138A (ja) * | 2014-10-20 | 2016-05-16 | 株式会社ファンケル | アミノ酸含有組成物 |
JP6189567B1 (ja) * | 2017-05-16 | 2017-08-30 | 森永製菓株式会社 | タンパク質含有顆粒の製造方法 |
JP2020145936A (ja) * | 2019-03-11 | 2020-09-17 | 理研ビタミン株式会社 | タンパク質含有粉末の水分散性改良剤 |
JP2021016383A (ja) * | 2019-07-18 | 2021-02-15 | 株式会社東洋新薬 | 経口組成物 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR1008627B (el) | 2013-07-26 | 2015-12-08 | ΕΛΛΗΝΙΚΗ ΠΡΩΤΕΪΝΗ ΕΜΠΟΡΙΚΗ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΤΑΣΚΕΥΑΣΤΙΚΗ ΕΙΣΑΓΩΓΙΚΗ ΕΞΑΓΩΓΙΚΗ Α.Ε. με δ.τ. "HELLENIC PROTEIN S.A." | Επεξεργασια υγρου ορου εκ στραγγιστου γιαουρτιου ελληνικου τυπου προς αποξηρανση για παραγωγη σκονης ορου προς αξιοποιηση |
AU2014306981B2 (en) * | 2013-08-14 | 2017-10-26 | Croda, Inc. | Adjuvancy combination |
KR101678024B1 (ko) | 2015-07-22 | 2016-11-21 | (주)금성계전 | 무선통신용 안테나 구조물 |
JP7285310B2 (ja) * | 2019-02-20 | 2023-06-01 | サントリーホールディングス株式会社 | 乳由来タンパク質含有顆粒状組成物、その製造方法及び乳由来タンパク質含有顆粒状組成物の分散性を改善する方法 |
WO2021054452A1 (ja) * | 2019-09-20 | 2021-03-25 | 株式会社明治 | ホエイタンパク質造粒物 |
USD986215S1 (en) * | 2021-07-20 | 2023-05-16 | Beyerdynamic Gmbh & Co. Kg | Headphone |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6322172A (ja) | 1986-03-11 | 1988-01-29 | Takeda Chem Ind Ltd | 食品用組成物およびその製造法 |
JPH08131083A (ja) * | 1994-11-14 | 1996-05-28 | Kao Corp | 大豆蛋白粉末及びその製造方法、並びに該粉末を用いた食品 |
JPH09313112A (ja) * | 1996-05-28 | 1997-12-09 | Fuji Oil Co Ltd | 粉末状大豆たん白及びその製造法 |
JPH1084868A (ja) | 1996-09-12 | 1998-04-07 | Nisshin Flour Milling Co Ltd | 代用乳組成物およびその製造方法 |
JP2001516599A (ja) * | 1997-09-22 | 2001-10-02 | セプラジェン コーポレーション | ホエータンパク質の逐次分離およびその配合物 |
JP2003189799A (ja) | 2001-12-27 | 2003-07-08 | Meiji Shiryo Kk | 家畜用代用乳の製造方法 |
WO2006035979A1 (ja) * | 2004-09-29 | 2006-04-06 | Asama Chemical Co., Ltd. | 乳清タンパク、乳由来の抗体または抗体を含む機能性組成物または食品 |
JP2006113189A (ja) | 2004-10-13 | 2006-04-27 | Olympus Corp | 鏡筒の検査装置及び鏡筒の検査方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3356507A (en) * | 1964-06-12 | 1967-12-05 | Borden Co | Lactalbumin phosphate lipid complex |
IE65045B1 (en) * | 1990-04-28 | 1995-10-04 | Takeda Chemical Industries Ltd | Granulated preparations and method of producing the same |
JPH06192113A (ja) * | 1992-09-25 | 1994-07-12 | Powrex:Kk | 生薬類の造粒方法および固形製剤 |
EP0616841B1 (en) * | 1992-10-09 | 1998-12-23 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Production method for fine granulate |
JP3606724B2 (ja) * | 1997-10-21 | 2005-01-05 | 三菱化学フーズ株式会社 | 乳蛋白含有粉末 |
-
2007
- 2007-04-17 JP JP2008512114A patent/JP5095610B2/ja active Active
- 2007-04-17 AU AU2007241926A patent/AU2007241926B2/en not_active Ceased
- 2007-04-17 US US12/226,354 patent/US8071153B2/en active Active
- 2007-04-17 EP EP07741765.7A patent/EP2027777B1/en not_active Not-in-force
- 2007-04-17 WO PCT/JP2007/058329 patent/WO2007123113A1/ja active Application Filing
- 2007-04-17 KR KR1020087026131A patent/KR101034411B1/ko active IP Right Grant
- 2007-04-17 CA CA2649619A patent/CA2649619C/en not_active Expired - Fee Related
- 2007-04-17 CN CN2007800179645A patent/CN101448406B/zh active Active
-
2009
- 2009-08-20 HK HK09107665.0A patent/HK1129815A1/xx not_active IP Right Cessation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6322172A (ja) | 1986-03-11 | 1988-01-29 | Takeda Chem Ind Ltd | 食品用組成物およびその製造法 |
JPH08131083A (ja) * | 1994-11-14 | 1996-05-28 | Kao Corp | 大豆蛋白粉末及びその製造方法、並びに該粉末を用いた食品 |
JPH09313112A (ja) * | 1996-05-28 | 1997-12-09 | Fuji Oil Co Ltd | 粉末状大豆たん白及びその製造法 |
JPH1084868A (ja) | 1996-09-12 | 1998-04-07 | Nisshin Flour Milling Co Ltd | 代用乳組成物およびその製造方法 |
JP2001516599A (ja) * | 1997-09-22 | 2001-10-02 | セプラジェン コーポレーション | ホエータンパク質の逐次分離およびその配合物 |
JP2003189799A (ja) | 2001-12-27 | 2003-07-08 | Meiji Shiryo Kk | 家畜用代用乳の製造方法 |
WO2006035979A1 (ja) * | 2004-09-29 | 2006-04-06 | Asama Chemical Co., Ltd. | 乳清タンパク、乳由来の抗体または抗体を含む機能性組成物または食品 |
JP2006113189A (ja) | 2004-10-13 | 2006-04-27 | Olympus Corp | 鏡筒の検査装置及び鏡筒の検査方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2027777A4 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009242308A (ja) * | 2008-03-31 | 2009-10-22 | Terumo Corp | 水易溶解性高たんぱく粉末栄養組成物およびその製造方法 |
JP2015188373A (ja) * | 2014-03-28 | 2015-11-02 | 株式会社ファンケル | 顆粒剤 |
JP2016079138A (ja) * | 2014-10-20 | 2016-05-16 | 株式会社ファンケル | アミノ酸含有組成物 |
JP6189567B1 (ja) * | 2017-05-16 | 2017-08-30 | 森永製菓株式会社 | タンパク質含有顆粒の製造方法 |
JP2018191557A (ja) * | 2017-05-16 | 2018-12-06 | 森永製菓株式会社 | タンパク質含有顆粒の製造方法 |
JP2020145936A (ja) * | 2019-03-11 | 2020-09-17 | 理研ビタミン株式会社 | タンパク質含有粉末の水分散性改良剤 |
JP7228415B2 (ja) | 2019-03-11 | 2023-02-24 | 理研ビタミン株式会社 | タンパク質含有粉末の水分散性改良剤 |
JP2021016383A (ja) * | 2019-07-18 | 2021-02-15 | 株式会社東洋新薬 | 経口組成物 |
Also Published As
Publication number | Publication date |
---|---|
US20090098274A1 (en) | 2009-04-16 |
KR20090007729A (ko) | 2009-01-20 |
KR101034411B1 (ko) | 2011-05-12 |
US8071153B2 (en) | 2011-12-06 |
EP2027777A4 (en) | 2013-05-29 |
AU2007241926B2 (en) | 2012-01-19 |
HK1129815A1 (en) | 2009-12-11 |
JPWO2007123113A1 (ja) | 2009-09-03 |
JP5095610B2 (ja) | 2012-12-12 |
CN101448406B (zh) | 2012-09-19 |
EP2027777A1 (en) | 2009-02-25 |
EP2027777B1 (en) | 2014-06-04 |
CA2649619A1 (en) | 2007-11-01 |
AU2007241926A1 (en) | 2007-11-01 |
CN101448406A (zh) | 2009-06-03 |
CA2649619C (en) | 2012-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007123113A1 (ja) | ホエープロテイン含有顆粒およびその製造方法 | |
JP6348837B2 (ja) | 易溶解性高タンパク含有粉末の製造方法及び易溶解性高タンパク含有粉末 | |
JP2007526211A (ja) | カッパ−2カラギーナンを含む均一かつ熱可逆性ゲルフィルムの伝達システム | |
JP2000041594A (ja) | 増粘用添加液 | |
CN102892310A (zh) | 结合脂肪的组合物 | |
JP4781208B2 (ja) | 粉末の造粒方法及び易分散・易溶解性顆粒組成物 | |
JP4044128B1 (ja) | タンパク質含有液状組成物用増粘化剤 | |
CA2605816C (en) | Rapidly soluble granules and method for producing the same | |
JP5192189B2 (ja) | 水溶性高分子のランピング防止方法及びランピングが防止された顆粒組成物 | |
AU2009314886B2 (en) | Acidic soluble protein-containing beverage composition and method for producing same | |
JP5388414B2 (ja) | 粉末の造粒方法 | |
JP5261004B2 (ja) | 水易溶解性高たんぱく粉末栄養組成物およびその製造方法 | |
JP4589251B2 (ja) | 粉末の造粒方法及び易溶性顆粒組成物 | |
JP2006052169A (ja) | ゾル状又はゲル状の服薬補助食品 | |
JP2004024182A (ja) | 溶解性が改善された水溶性高分子 | |
JP6800861B2 (ja) | 増粘多糖類含有製剤の製造方法 | |
WO2004078334A1 (ja) | 多糖と蛋白質との複合体を有効成分とする乳化剤およびその製造方法ならびに乳化組成物 | |
JP4418781B2 (ja) | プロポリス粉末の製造方法 | |
JP2018191557A (ja) | タンパク質含有顆粒の製造方法 | |
JPWO2020171069A1 (ja) | タンパク質含有経口組成物及びタンパク質含有経口組成物の風味改善方法 | |
WO2017002718A1 (ja) | 継粉形成抑制剤 | |
JP2017055763A (ja) | 糊料製剤 | |
JP2003049190A (ja) | 新規な高分岐環状デキストリンを含有する粉末状油脂及びその製造方法及びそれを利用した飲食物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780017964.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07741765 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2008512114 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12226354 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007241926 Country of ref document: AU Ref document number: 2649619 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087026131 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007741765 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2007241926 Country of ref document: AU Date of ref document: 20070417 Kind code of ref document: A |